tiprankstipranks
Vigil Neuroscience reports Q1 EPS (50c), consensus (61c)
PremiumThe FlyVigil Neuroscience reports Q1 EPS (50c), consensus (61c)
3M ago
Vigil says interim IGNITE Phase 2 data demonstrate VGL101 potential for ALSP
PremiumThe Fly
Vigil says interim IGNITE Phase 2 data demonstrate VGL101 potential for ALSP
3M ago
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
PremiumPress Releases
Vigil Presents Key Findings from ILLUMINATE & IGNITE Studies in ALSP at the 2024 American Academy of Neurology Annual Meeting
3M ago
Vigil Neuroscience appoints Kaufmann as Chief Medical Officer
PremiumThe FlyVigil Neuroscience appoints Kaufmann as Chief Medical Officer
4M ago
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
PremiumPress Releases
Vigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief Medical Officer
4M ago
VIGL Earnings this Week: How Will it Perform?
PremiumPre-Earnings
VIGL Earnings this Week: How Will it Perform?
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100